• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

layoffs

Layoffs
Biotech

nChroma halves headcount, halts trial of potential HBV ‘cure’

nChroma’s workforce is facing another round of layoffs, with the Boston biotech halving its headcount and halting its lead hepatitis asset.
James Waldron Nov 19, 2026 9:08am
A series of dice with a bag on them illustrating cost cuts

Cellectis will shed 70% of workforce as part of in vivo pivot

Nov 13, 2026 9:18am
x

Fierce Biotech Layoff Tracker 2026: Milestone, Cellectis & more

Nov 13, 2026 7:00am
a lot of scissors

Capricor, NextCure shed light on recent layoffs

Nov 11, 2026 4:48am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Coherus shrinks headcount 30% to narrow focus of cancer combo

Nov 10, 2026 3:52am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Agios shedding 100 R&D roles ahead of hoped-for SCD approval

Nov 5, 2026 8:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings